Your browser doesn't support javascript.
loading
Direct Promoter Repression by BCL11A Controls the Fetal to Adult Hemoglobin Switch.
Liu, Nan; Hargreaves, Victoria V; Zhu, Qian; Kurland, Jesse V; Hong, Jiyoung; Kim, Woojin; Sher, Falak; Macias-Trevino, Claudio; Rogers, Julia M; Kurita, Ryo; Nakamura, Yukio; Yuan, Guo-Cheng; Bauer, Daniel E; Xu, Jian; Bulyk, Martha L; Orkin, Stuart H.
Afiliación
  • Liu N; Cancer and Blood Disorders Center, Dana Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
  • Hargreaves VV; Cancer and Blood Disorders Center, Dana Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
  • Zhu Q; Department of Biostatistics and Computational Biology, Dana Farber Cancer Institute and Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Kurland JV; Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Hong J; Cancer and Blood Disorders Center, Dana Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
  • Kim W; Cancer and Blood Disorders Center, Dana Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
  • Sher F; Cancer and Blood Disorders Center, Dana Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
  • Macias-Trevino C; Cancer and Blood Disorders Center, Dana Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
  • Rogers JM; Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Committee on Higher Degrees in Biophysics, Harvard University, Cambridge, MA, USA.
  • Kurita R; Cell Engineering Division, RIKEN Bioresource Center, Tsukuba, Japan.
  • Nakamura Y; Cell Engineering Division, RIKEN Bioresource Center, Tsukuba, Japan.
  • Yuan GC; Department of Biostatistics and Computational Biology, Dana Farber Cancer Institute and Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Bauer DE; Cancer and Blood Disorders Center, Dana Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
  • Xu J; Children's Medical Center Research Institute, Department of Pediatrics, University of Texas at Southwestern Medical Center, Dallas, TX, USA.
  • Bulyk ML; Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Committee on Higher Degrees in Biophysics, Harvard University, Cambridge, MA, USA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Orkin SH; Cancer and Blood Disorders Center, Dana Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA, USA; Howard Hughes Medical Institute, Boston, MA, USA. Electronic address: stuart_orkin@dfci.harvard.edu.
Cell ; 173(2): 430-442.e17, 2018 04 05.
Article en En | MEDLINE | ID: mdl-29606353
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hemoglobina Fetal / Proteínas Nucleares / Proteínas Portadoras Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cell Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hemoglobina Fetal / Proteínas Nucleares / Proteínas Portadoras Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cell Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos